Information Other Links Introduction Antimicrobials have transformed our ability to treat many infectious diseases that were killers only a few decades ago. The increasing use of antimicrobials in humans, animals, and agriculture has resulted in many pathogens developing resistance to these powerful drugs. Before the Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Public Health and Safety.
Improved diagnosis allows infections to be treated appropiately.
Vaccines are important because they prevent infection from getting established, thereby avoiding the need to treat and the associated problem of antimicrobial resistance. Microbial genome sequencing activities will provide clues to the genetic basis of resistance and may identify new proteins and genes to target with drugs and vaccines. In addition, clinical trials evaluate new or improved products for diagnosing, treating, and prevention. The Bacteriology and Mycology Study Group will design and conduct multicenter clinical studies of interventions for serious fungal and healthcare associated resistant bacterial infections. The Challenge Grant Program promotes joint ventures between NIH and the industry to support research and development of products that could significantly decrease the impact of infectious diseases.